McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Vanguard Total Stock Mkt Idx Inv

Vanguard Institutional 500 Index Trust

Vanguard Value Index Inv

The Health Care Select Sector SPDR® ETF

Vanguard Institutional Index I

BGF World Healthscience A2

Vanguard Dividend Appreciation ETF

State St S&P 500® Indx SL Cl III

T. Rowe Price US Dividend Growth Eq Comp

T. Rowe Price Dividend Growth

iShares MSCI USA Min Vol Factor ETF

Blackrock Eq Idx Fund CF

MFS Large Cap Value Equity

MFS Value A

SPDR® S&P 500® ETF Trust

Fidelity 500 Index

iShares Core S&P 500 ETF

JPMorgan Large Cap Growth I

Putnam Large Cap Value A

Putnam US Large Cap Value Equity

Vanguard Group Inc

BlackRock Inc

NORGES BANK

Bank of America Corp

Royal Bank of Canada

Northern Trust Corp

T. Rowe Price Associates, Inc.

Legal & General Group PLC

Manufacturers Life Insurance Co

Arrowstreet Capital Limited Partnership

WCM Investment Management

Amvescap Plc.

State Street Corp

Massachusetts Financial Services Company

JPMorgan Chase & Co

FMR Inc

Geode Capital Management, LLC

T. Rowe Price Investment Management,Inc.

Franklin Resources Inc

Morgan Stanley - Brokerage Accounts

McKesson Corporation

Mr. Brian S. Tyler Ph.D.

CEO & Director

Mr. Britt J. Vitalone CPA

Executive VP & CFO

Ms. Michele  Lau J.D.

Executive VP & Chief Legal Officer

Ms. LeAnn B. Smith

Executive VP & Chief Human Resources Officer

Mr. Thomas L. Rodgers M.B.A.

Executive VP and Chief Strategy & Business Development Officer

Mr. Napoleon B. Rutledge Jr.

Senior VP, Controller & Chief Accounting Officer

Mr. Francisco  Fraga

Executive VP, Chief Information Officer & Chief Technology Officer

Ms. Rachel  Rodriguez

Vice President of Investor Relations

Mr. Pete  Slone

Senior Vice President of Corporate Public Affairs

Mr. Kirk  Kaminsky

President of The US Pharmaceutical & Specialty Solutions Business

MCK's next earnings is on February 5, 2025 (Before Market Open)

MCK's latest dividend is 0.71 USD on August 30, 2024

McKesson Corporation (MCK) Stock Analysis, Discussion Forum and Financial Metrics - NYSE Exchange

McKesson Corporation (MCK) Earnings Report Date and History | NYSE

MCK's next earnings is on February 5, 2025 (Before Market Open)

When is the earnings report for MCK?

MCK Earnings History

MCK's latest dividend is 0.71 USD on August 30, 2024

MCK Stock Discussion Forum and Message Board

News for NYSE: MCK